{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T14:34:59Z","timestamp":1774276499202,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T00:00:00Z","timestamp":1513814400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BPD\/74868\/2010"],"award-info":[{"award-number":["SFRH\/BPD\/74868\/2010"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BPD\/111736\/2015"],"award-info":[{"award-number":["SFRH\/BPD\/111736\/2015"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s00204-017-2146-z","type":"journal-article","created":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T01:03:55Z","timestamp":1513818235000},"page":"1205-1214","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Combination of etoposide and fisetin results in anti-cancer efficiency against osteosarcoma cell models"],"prefix":"10.1007","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3883-0806","authenticated-orcid":false,"given":"Jos\u00e9 Miguel P.","family":"Ferreira de Oliveira","sequence":"first","affiliation":[]},{"given":"Ana Rita","family":"Pacheco","sequence":"additional","affiliation":[]},{"given":"Laura","family":"Coutinho","sequence":"additional","affiliation":[]},{"given":"Helena","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"S\u00f3nia","family":"Pinho","sequence":"additional","affiliation":[]},{"given":"Luis","family":"Almeida","sequence":"additional","affiliation":[]},{"given":"Eduarda","family":"Fernandes","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4129-6381","authenticated-orcid":false,"given":"Concei\u00e7\u00e3o","family":"Santos","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2017,12,21]]},"reference":[{"key":"2146_CR1","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1117\/1.3589100","volume":"11","author":"MD Abr\u00e0moff","year":"2004","unstructured":"Abr\u00e0moff MD, Magalh\u00e3es PJ, Ram SJ (2004) Image processing with imageJ. Biophoton Int 11:36\u201341. \n                        https:\/\/doi.org\/10.1117\/1.3589100","journal-title":"Biophoton Int"},{"key":"2146_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-015-4118-3","author":"A Adan","year":"2015","unstructured":"Adan A, Baran Y (2015) Fisetin and hesperetin induced apoptosis and cell cycle arrest in chronic myeloid leukemia cells accompanied by modulation of cellular signaling. Tumor Biol. \n                        https:\/\/doi.org\/10.1007\/s13277-015-4118-3","journal-title":"Tumor Biol"},{"key":"2146_CR3","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ocl.2015.08.022","volume":"47","author":"ME Anderson","year":"2016","unstructured":"Anderson ME (2016) Update on Survival in Osteosarcoma. Orthop Clin North Am 47:283\u2013292. \n                        https:\/\/doi.org\/10.1016\/j.ocl.2015.08.022","journal-title":"Orthop Clin North Am"},{"key":"2146_CR4","doi-asserted-by":"publisher","first-page":"11014","DOI":"10.1073\/pnas.0704002104","volume":"104","author":"AM Azarova","year":"2007","unstructured":"Azarova AM, Lyu YL, Lin C et al (2007) Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies. Proc Natl Acad Sci USA 104:11014\u201311019. \n                        https:\/\/doi.org\/10.1073\/pnas.0704002104","journal-title":"Proc Natl Acad Sci USA"},{"key":"2146_CR5","doi-asserted-by":"publisher","first-page":"6097","DOI":"10.1021\/bi7000664","volume":"46","author":"OJ Bandele","year":"2007","unstructured":"Bandele OJ, Osheroff N (2007) Bioflavonoids as poisons of human topoisomerase II alpha and II beta. Biochemistry 46:6097\u20136108. \n                        https:\/\/doi.org\/10.1021\/bi7000664","journal-title":"Biochemistry"},{"key":"2146_CR6","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00204-002-0346-6","volume":"76","author":"YC Chen","year":"2002","unstructured":"Chen YC, Shen SC, Lee WR et al (2002) Wogonin and fisetin induction of apoptosis through activation of caspase 3 cascade and alternative expression of p21 protein in hepatocellular carcinoma cells SK-HEP-1. Arch Toxicol 76:351\u2013359. \n                        https:\/\/doi.org\/10.1007\/s00204-002-0346-6","journal-title":"Arch Toxicol"},{"key":"2146_CR7","doi-asserted-by":"publisher","first-page":"810563","DOI":"10.1155\/2012\/810563","volume":"2012","author":"SW Choi","year":"2012","unstructured":"Choi SW, Son YJ, Yun JM, Kim SH (2012) Fisetin inhibits osteoclast differentiation via downregulation of p38 and c-Fos-NFATc1 signaling pathways. Evid based Complement Alternat Med 2012:810563. \n                        https:\/\/doi.org\/10.1155\/2012\/810563","journal-title":"Evid based Complement Alternat Med"},{"key":"2146_CR8","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1124\/pr.58.3.10","volume":"58","author":"T Chou","year":"2006","unstructured":"Chou T (2006) Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 58:621\u2013681. \n                        https:\/\/doi.org\/10.1124\/pr.58.3.10","journal-title":"Pharmacol Rev"},{"key":"2146_CR9","volume-title":"CompuSyn for drug combinations: PC software and user\u2019s guide: a computer program for quantitation of synergism and antagonism in drug combinations, and the determination of IC50 and ED50 and LD50 values","author":"TC Chou","year":"2005","unstructured":"Chou TC, Martin N (2005) CompuSyn for drug combinations: PC software and user\u2019s guide: a computer program for quantitation of synergism and antagonism in drug combinations, and the determination of IC50 and ED50 and LD50 values. ComboSyn Inc, Paramus"},{"key":"2146_CR10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.dnarep.2016.12.006","volume":"50","author":"L Coutinho","year":"2017","unstructured":"Coutinho L, Oliveira H, Pacheco AR et al (2017) Hesperetin-etoposide combinations induce cytotoxicity in U2OS cells: Implications on therapeutic developments for osteosarcoma. DNA Repair 50:36\u201342. \n                        https:\/\/doi.org\/10.1016\/j.dnarep.2016.12.006","journal-title":"DNA Repair"},{"key":"2146_CR11","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.bone.2013.12.021","volume":"60","author":"R Fiore Di","year":"2014","unstructured":"Di Fiore R, Marcatti M, Drago-Ferrante R et al (2014) Mutant p53 gain of function can be at the root of dedifferentiation of human osteosarcoma MG63 cells into 3AB-OS cancer stem cells. Bone 60:198\u2013212. \n                        https:\/\/doi.org\/10.1016\/j.bone.2013.12.021","journal-title":"Bone"},{"key":"2146_CR12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/01635581.2014.864777","volume":"5581","author":"JMP Ferreira de Oliveira","year":"2014","unstructured":"Ferreira de Oliveira JMP, Rem\u00e9dios C, Oliveira H et al (2014) Sulforaphane induces DNA damage and mitotic abnormalities in human osteosarcoma MG-63 cells: correlation with cell cycle Arrest and apoptosis. Nutr Cancer 5581:37\u201341. \n                        https:\/\/doi.org\/10.1080\/01635581.2014.864777","journal-title":"Nutr Cancer"},{"key":"2146_CR13","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.2174\/092986708784911579","volume":"15","author":"A Gomes","year":"2008","unstructured":"Gomes A, Fernandes E, Lima JLFC. et al (2008) Molecular mechanisms of anti-inflammatory activity mediated by flavonoids. Curr Med Chem 15:1586\u20131605","journal-title":"Curr Med Chem"},{"key":"2146_CR14","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1017\/S0007114510003910","volume":"104","author":"J Gonz\u00e1lez-Gallego","year":"2010","unstructured":"Gonz\u00e1lez-Gallego J, Garc\u00eda-Mediavilla MV, S\u00e1nchez-Campos S, Tu\u00f1\u00f3n MJ (2010) Fruit polyphenols, immunity and inflammation. Br J Nutr 104:S15\u2013S27. \n                        https:\/\/doi.org\/10.1017\/S0007114510003910","journal-title":"Br J Nutr"},{"key":"2146_CR15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/sj.pcan.4500845","volume":"9","author":"AQ Haddad","year":"2006","unstructured":"Haddad AQ, Venkateswaran V, Viswanathan L et al (2006) Novel antiproliferative flavonoids induce cell cycle arrest in human prostate cancer cell lines. Prostate Cancer Prostatic Dis 9:68\u201376. \n                        https:\/\/doi.org\/10.1038\/sj.pcan.4500845","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"2146_CR16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2174\/1874467211205020205","volume":"5","author":"MN Horcajada","year":"2012","unstructured":"Horcajada MN, Offord E (2012) Naturally plant-derived compounds: role in bone anabolism. Curr Mol Pharmacol 5:205\u2013218. \n                        https:\/\/doi.org\/10.2174\/1874467211205020205","journal-title":"Curr Mol Pharmacol"},{"key":"2146_CR17","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/nrc3838","volume":"14","author":"M Kansara","year":"2014","unstructured":"Kansara M, Teng MW, Smyth MJ, Thomas DM (2014) Translational biology of osteosarcoma. Nat Rev Cancer 14:722\u2013735. \n                        https:\/\/doi.org\/10.1038\/nrc3838","journal-title":"Nat Rev Cancer"},{"key":"2146_CR18","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1093\/carcin\/bgn078","volume":"29","author":"N Khan","year":"2008","unstructured":"Khan N, Afaq F, Syed DN, Mukhtar H (2008) Fisetin, a novel dietary flavonoid, causes apoptosis and cell cycle arrest in human prostate cancer LNCaP cells. Carcinogenesis 29:1049\u20131056. \n                        https:\/\/doi.org\/10.1093\/carcin\/bgn078","journal-title":"Carcinogenesis"},{"key":"2146_CR19","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jnutbio.2013.11.003","volume":"25","author":"YH Kim","year":"2014","unstructured":"Kim YH, Kim JL, Lee EJ et al (2014) Fisetin antagonizes cell fusion, cytoskeletal organization and bone resorption in RANKL-differentiated murine macrophages. J Nutr Biochem 25:295\u2013303. \n                        https:\/\/doi.org\/10.1016\/j.jnutbio.2013.11.003","journal-title":"J Nutr Biochem"},{"key":"2146_CR20","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.intimp.2008.11.005","volume":"9","author":"JD Lee","year":"2009","unstructured":"Lee JD, Huh JE, Jeon GS et al (2009) Flavonol-rich RVHxR from Rhus verniciflua Stokes and its major compound fisetin inhibits inflammation-related cytokines and angiogenic factor in rheumatoid arthritic fibroblast-like synovial cells and in vivo models. Int Immunopharmacol 9:268\u2013276. \n                        https:\/\/doi.org\/10.1016\/j.intimp.2008.11.005","journal-title":"Int Immunopharmacol"},{"key":"2146_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0068388","volume":"8","author":"L L\u00e9otoing","year":"2013","unstructured":"L\u00e9otoing L, Wauquier F, Guicheux J et al (2013) The polyphenol fisetin protects bone by repressing NF-kappaB and MKP-1-dependent signaling pathways in osteoclasts. PLoS One 8:1\u201314. \n                        https:\/\/doi.org\/10.1371\/journal.pone.0068388","journal-title":"PLoS One"},{"key":"2146_CR22","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1002\/mnfr.201300836","volume":"58","author":"L L\u00e9otoing","year":"2014","unstructured":"L\u00e9otoing L, Davicco MJ, Lebecque P et al (2014) The flavonoid fisetin promotes osteoblasts differentiation through Runx2 transcriptional activity. Mol Nutr Food Res 58:1239\u20131248. \n                        https:\/\/doi.org\/10.1002\/mnfr.201300836","journal-title":"Mol Nutr Food Res"},{"key":"2146_CR23","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1742-7843.2010.00613.x","volume":"108","author":"J Li","year":"2011","unstructured":"Li J, Cheng Y, Qu W et al (2011) Fisetin, a dietary flavonoid, induces cell cycle arrest and apoptosis through activation of p53 and inhibition of NF-kappa B pathways in bladder cancer cells. Basic Clin Pharmacol Toxicol 108:84\u201393. \n                        https:\/\/doi.org\/10.1111\/j.1742-7843.2010.00613.x","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2146_CR24","doi-asserted-by":"publisher","first-page":"820","DOI":"10.3329\/bjp.v10i4.23039","volume":"10","author":"JM Li","year":"2015","unstructured":"Li JM, Li WY, Huang MY, Zhang XQ (2015) Fisetin, a dietary flavonoid induces apoptosis via modulating the MAPK and PI3K\/Akt signalling pathways in human osteosarcoma (U-2 OS) cells. Bangladesh J Pharmacol 10:820\u2013829. \n                        https:\/\/doi.org\/10.3329\/bjp.v10i4.23039","journal-title":"Bangladesh J Pharmacol"},{"key":"2146_CR25","doi-asserted-by":"publisher","first-page":"8933","DOI":"10.1021\/jf902630w","volume":"57","author":"Y-C Liao","year":"2009","unstructured":"Liao Y-C, Shih Y-W, Chao C-H et al (2009) Involvement of the ERK signaling pathway in fisetin reduces invasion and migration in the human lung cancer cell line A549. J Agric Food Chem 57:8933\u20138941. \n                        https:\/\/doi.org\/10.1021\/jf902630w","journal-title":"J Agric Food Chem"},{"key":"2146_CR26","doi-asserted-by":"publisher","first-page":"G1060","DOI":"10.1152\/ajpgi.90490.2008","volume":"296","author":"DY Lim","year":"2009","unstructured":"Lim DY, Park JHY (2009) Induction of p53 contributes to apoptosis of HCT-116 human colon cancer cells induced by the dietary compound fisetin. Am J Physiol Gastrointest Liver Physiol 296:G1060\u2013G1068. \n                        https:\/\/doi.org\/10.1152\/ajpgi.90490.2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2146_CR27","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.jmoldx.2010.11.020","volume":"13","author":"WW Lockwood","year":"2011","unstructured":"Lockwood WW, Stack D, Morris T et al (2011) Cyclin E1 is amplified and overexpressed in osteosarcoma. J Mol Diagn 13:289\u2013296. \n                        https:\/\/doi.org\/10.1016\/j.jmoldx.2010.11.020","journal-title":"J Mol Diagn"},{"key":"2146_CR28","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1093\/jn\/135.12.2884","volume":"135","author":"X Lu","year":"2005","unstructured":"Lu X, Jung J, Cho HJ et al (2005) Fisetin inhibits the activities of cyclin-dependent kinases leading to cell cycle arrest in HT-29 human colon cancer cells. J Nutr 135:2884\u20132890","journal-title":"J Nutr"},{"key":"2146_CR29","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.ctrv.2013.11.006","volume":"40","author":"A Luetke","year":"2014","unstructured":"Luetke A, Meyers PA, Lewis I, Juergens H (2014) Osteosarcoma treatment\u2014Where do we stand? A state of the art review. Cancer Treat Rev 40:523\u2013532. \n                        https:\/\/doi.org\/10.1016\/j.ctrv.2013.11.006","journal-title":"Cancer Treat Rev"},{"key":"2146_CR30","doi-asserted-by":"publisher","first-page":"7716","DOI":"10.1073\/pnas.84.21.7716","volume":"84","author":"H Masuda","year":"1987","unstructured":"Masuda H, Miller C, Koeffler HP et al (1987) Rearrangement of the p53 gene in human osteogenic sarcomas. Proc Natl Acad Sci USA 84:7716\u20137719. \n                        https:\/\/doi.org\/10.1073\/pnas.84.21.7716","journal-title":"Proc Natl Acad Sci USA"},{"key":"2146_CR31","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1002\/ijc.24628","volume":"125","author":"I Murtaza","year":"2009","unstructured":"Murtaza I, Adhami VM, Hafeez B, Bin et al (2009) Fisetin, a natural flavonoid, targets chemoresistant human pancreatic cancer AsPC-1 cells through DR3-mediated inhibition of NF-\u03baB. Int J Cancer 125:2465\u20132473. \n                        https:\/\/doi.org\/10.1002\/ijc.24628","journal-title":"Int J Cancer"},{"key":"2146_CR32","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/exd.12181.Fisetin","volume":"22","author":"HC Pal","year":"2013","unstructured":"Pal HC, Sharma S, Elmets CA et al (2013) Fisetin inhibits growth, induces G2\/M arrest and apoptosis of human epidermoid carcinoma A431 cells: role of mitochondrial membrane potential disruption and consequent caspases activation. Exp Dermatol 22:470\u2013475. \n                        https:\/\/doi.org\/10.1111\/exd.12181.Fisetin","journal-title":"Exp Dermatol"},{"key":"2146_CR33","doi-asserted-by":"publisher","first-page":"270","DOI":"10.4161\/oxim.2.5.9498","volume":"2","author":"KB Pandey","year":"2009","unstructured":"Pandey KB, Rizvi SI (2009) Plant polyphenols as dietary antioxidants in human health and disease. Oxidative Med Cell Longev 2:270\u2013278. \n                        https:\/\/doi.org\/10.4161\/oxim.2.5.9498","journal-title":"Oxidative Med Cell Longev"},{"key":"2146_CR34","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:16\u201321. \n                        https:\/\/doi.org\/10.1093\/nar\/29.9.e45","journal-title":"Nucleic Acids Res"},{"key":"2146_CR35","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1385\/1-59259-192-2:365","volume":"132","author":"S Rozen","year":"2000","unstructured":"Rozen S, Skaletsky H (2000) Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132:365\u2013386. \n                        https:\/\/doi.org\/10.1385\/1-59259-192-2:365","journal-title":"Methods Mol Biol"},{"key":"2146_CR36","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1254\/jphs.12243FP","volume":"121","author":"E Sakai","year":"2013","unstructured":"Sakai E, Shimada-Sugawara M, Yamaguchi Y et al (2013) Fisetin inhibits osteoclastogenesis through prevention of RANKL-induced ROS production by Nrf2-mediated up-regulation of phase II antioxidant enzymes. J Pharmacol Sci 121:288\u2013298. \n                        https:\/\/doi.org\/10.1254\/jphs.12243FP","journal-title":"J Pharmacol Sci"},{"key":"2146_CR37","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.nutres.2012.09.018","volume":"32","author":"CL Shen","year":"2012","unstructured":"Shen CL, von Bergen V, Chyu MC et al (2012) Fruits and dietary phytochemicals in bone protection. Nutr Res 32:897\u2013910. \n                        https:\/\/doi.org\/10.1016\/j.nutres.2012.09.018","journal-title":"Nutr Res"},{"key":"2146_CR38","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.1073\/pnas.070061297","volume":"97","author":"R Strick","year":"2000","unstructured":"Strick R, Strissel PL, Borgers S et al (2000) Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia. Proc Natl Acad Sci USA 97:4790\u20134795. \n                        https:\/\/doi.org\/10.1073\/pnas.070061297","journal-title":"Proc Natl Acad Sci USA"},{"key":"2146_CR39","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1093\/carcin\/bgn269","volume":"30","author":"Y Suh","year":"2009","unstructured":"Suh Y, Afaq F, Johnson JJ, Mukhtar H (2009) A plant flavonoid fisetin induces apoptosis in colon cancer cells by inhibition of COX2 and Wnt\/EGFR\/NF-\u03baB-signaling pathways. Carcinogenesis 30:300\u2013307. \n                        https:\/\/doi.org\/10.1093\/carcin\/bgn269","journal-title":"Carcinogenesis"},{"key":"2146_CR40","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1124\/mol.107.034512","volume":"71","author":"B Sung","year":"2007","unstructured":"Sung B, Pandey MK, Aggarwal BB (2007) Fisetin, an inhibitor of cyclin-dependent kinase 6, down\u2014regulates nuclear factor-\u03baB-regulated cell proliferation, antiapoptotic and metastatic gene products through the suppression of TAK-1 and receptor-interacting protein\u2014regulated I\u03baB\u03b1 kinase activ. Mol Pharmacol 71:1703\u20131714. \n                        https:\/\/doi.org\/10.1124\/mol.107.034512","journal-title":"Mol Pharmacol"},{"key":"2146_CR41","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1038\/jid.2011.6","volume":"131","author":"DN Syed","year":"2011","unstructured":"Syed DN, Afaq F, Maddodi N et al (2011) Inhibition of human melanoma cell growth by the dietary flavonoid fisetin is associated with disruption of Wnt\/\u03b2-catenin signaling and decreased Mitf levels. J Invest Dermatol 131:1291\u20131299. \n                        https:\/\/doi.org\/10.1038\/jid.2011.6","journal-title":"J Invest Dermatol"},{"key":"2146_CR42","doi-asserted-by":"publisher","unstructured":"Touil YS, Auzeil N, Saighi H et al (2011a) Fisetin disposition and metabolism in mice: Identification of geraldol as an active metabolite. 82:1731\u20131739. \n                        https:\/\/doi.org\/10.1016\/j.bcp.2011.07.097","DOI":"10.1016\/j.bcp.2011.07.097"},{"key":"2146_CR43","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00280-010-1505-8","volume":"68","author":"YS Touil","year":"2011","unstructured":"Touil YS, Seguin J, Scherman D, Chabot GG (2011b) Improved antiangiogenic and antitumour activity of the combination of the natural flavonoid fisetin and cyclophosphamide in Lewis lung carcinoma-bearing mice. Cancer Chemother Pharmacol 68:445\u2013455. \n                        https:\/\/doi.org\/10.1007\/s00280-010-1505-8","journal-title":"Cancer Chemother Pharmacol"},{"key":"2146_CR44","doi-asserted-by":"publisher","first-page":"e0166233","DOI":"10.1371\/journal.pone.0166233","volume":"11","author":"S Vella","year":"2016","unstructured":"Vella S, Tavanti E, Hattinger CM et al (2016) Targeting CDKs with roscovitine increases sensitivity to DNA damaging drugs of human osteosarcoma cells. PLoS One 11:e0166233. \n                        https:\/\/doi.org\/10.1371\/journal.pone.0166233","journal-title":"PLoS One"},{"key":"2146_CR45","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1081\/CNV-120002156","volume":"20","author":"JV Walker","year":"2002","unstructured":"Walker JV, Nitiss JL (2002) DNA topoisomerase II as a target for cancer chemotherapy. Cancer Invest 20:570\u2013589. \n                        https:\/\/doi.org\/10.1081\/CNV-120002156","journal-title":"Cancer Invest"},{"key":"2146_CR46","doi-asserted-by":"publisher","first-page":"4859","DOI":"10.1007\/s13277-014-1637-2","volume":"35","author":"J Wang","year":"2014","unstructured":"Wang J, Xu G, Shen F, Kang Y (2014) miR-132 targeting cyclin E1 suppresses cell proliferation in osteosarcoma cells. Tumor Biol 35:4859\u20134865. \n                        https:\/\/doi.org\/10.1007\/s13277-014-1637-2","journal-title":"Tumor Biol"},{"key":"2146_CR47","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1097\/CCO.0b013e3283622c1b","volume":"25","author":"J Yang","year":"2013","unstructured":"Yang J, Zhang W (2013) New molecular insights into osteosarcoma targeted therapy. Curr Opin Oncol 25:398\u2013406. \n                        https:\/\/doi.org\/10.1097\/CCO.0b013e3283622c1b","journal-title":"Curr Opin Oncol"},{"key":"2146_CR48","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00204-011-0754-6","volume":"86","author":"TH Ying","year":"2012","unstructured":"Ying TH, Yang SF, Tsai SJ et al (2012) Fisetin induces apoptosis in human cervical cancer HeLa cells through ERK1\/2-mediated activation of caspase-8-\/caspase-3-dependent pathway. Arch Toxicol 86:263\u2013273. \n                        https:\/\/doi.org\/10.1007\/s00204-011-0754-6","journal-title":"Arch Toxicol"},{"key":"2146_CR49","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1089\/cmb.2005.12.1047.Comprehensive","volume":"12","author":"S Zhao","year":"2005","unstructured":"Zhao S, Fernald RD (2005) Comprehensive algorithm for quantitative real-time polymerase chain reaction. J Comput Biol 12:1047\u20131064. \n                        https:\/\/doi.org\/10.1089\/cmb.2005.12.1047.Comprehensive","journal-title":"J Comput Biol"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00204-017-2146-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-017-2146-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-017-2146-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,24]],"date-time":"2018-03-24T06:26:49Z","timestamp":1521872809000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00204-017-2146-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,21]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["2146"],"URL":"https:\/\/doi.org\/10.1007\/s00204-017-2146-z","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,21]]}}}